| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $50K | -80.5% |
| Cost of Revenue | $106K | -52.0% |
| Gross Profit | -$56K | -256.9% |
| R&D Expense | $1.4M | -2.2% |
| SG&A Expense | $3.3M | +2072.3% |
| Operating Income | -$5.9M | -2.5% |
| Interest Expense | $449K | +8886.1% |
| Pre-tax Income | -$10.1M | -15.9% |
| Net Income | -$10.1M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $281 | — |
| Accounts Receivable | $50K | — |
| Current Assets | $128K | +905.1% |
| Total Assets | $148K | -96.7% |
| Current Liabilities | $2.4M | -70.1% |
| Total Liabilities | $2.4M | -70.9% |
| Stockholders' Equity | -$2.2M | +39.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.4M | -101.0% |
| Capital Expenditures | $2K | — |
| Investing Cash Flow | -$2K | — |
| Financing Cash Flow | $5.4M | +171.3% |
| Free Cash Flow | -$5.4M | — |
| -15.9% |
| EPS (Basic) | -$0.02 | +99.1% |
| EPS (Diluted) | -$0.02 | +99.1% |